Quick Answer
A single unprotected encounter with a randomly-selected partner carries meaningful STI risk — roughly 25% chance one party has some infection in higher-prevalence demographics, with per-act transmission odds varying enormously by infection and act.
- Per-act female-to-male HIV transmission averages ~0.04% (vaginal); receptive anal runs ~1.4%.
- Gonorrhea transmits efficiently per act — estimates exceed 50% male-to-female during vaginal sex.
- HPV and herpes spread readily in single encounters via skin contact.
- Condoms reduce these figures by 80–98%, transforming single-encounter risk profiles.
Which Infections Actually Transfer This Way?
Population prevalence times per-act efficiency yields encounter risk. Young adult populations carry chlamydia rates near 3–5%, HPV near 40% prevalence overall, and herpes around 1-in-6 — multiplying against per-act efficiencies produces non-trivial single-night mathematics.
Why People Worry About This Route
Post-hookup anxiety searches outnumber actual infections substantially — but the anxiety serves a function: it drives exactly the testing behavior that catches the minority of real exposures early. Channel it productively rather than catastrophizing.
If You Think You Were Exposed
Timing decides your next move. Chlamydia and gonorrhea appear reliably on NAAT urine or swab tests within 1–2 weeks, syphilis needs 3–6 weeks, HIV shows on a modern 4th-generation lab test within 18–45 days, and herpes blood tests become dependable at 12–16 weeks. For HIV specifically, PEP medication within 72 hours can stop an infection before it starts.
| Infection | Reliable detection window | Typical test |
|---|---|---|
| Gonorrhea | 1–2 weeks | NAAT urine or swab |
| Chlamydia | 1–2 weeks | NAAT urine or swab |
| Syphilis | 3–6 weeks | Blood (RPR plus treponemal confirm) |
| HIV (4th-gen lab) | 18–45 days | Blood draw |
| HIV (rapid oral) | 23–90 days | Finger-stick or oral fluid |
| Hepatitis C | 2–6 months (RNA sooner) | Blood |
| Hepatitis B | 3–6 weeks | Blood (HBsAg) |
| Herpes (IgG blood) | 12–16 weeks | Type-specific IgG blood |
| Herpes (lesion swab) | While sores present | PCR swab of a sore |
| Trichomoniasis | 1–4 weeks | NAAT urine or swab |
| HPV | Ongoing screening; no timed test | Cervical HPV DNA (screening ages 25+) |
Sensible Precautions Going Forward
Test at appropriate window periods (2 weeks minimum, HIV at 6 weeks and 3 months for certainty). Consider HIV PEP within 72 hours if the partner's status was unknown AND anal receptive sex occurred. Going forward: condoms plus periodic panel testing normalize safety without killing spontaneity.
Sources & Further Reading
- CDC — Sexually Transmitted Infections
- CDC STI Treatment Guidelines
- WHO — Sexually transmitted infections fact sheet
- MedlinePlus — Sexually Transmitted Diseases
Figures reflect CDC surveillance and WHO estimates; they are population statistics, not personal risk predictions.